The epidemiology, inflammatory pathophysiology, diagnosis, and treatment of diabetic macular edema are discussed during Inflammatory Eye Disease Week.
Feature|Articles|September 30, 2026
Pediatric progressive myopia is an epidemic causing permanent vision loss
Author(s)Nimesh Patel, MD
Fact checked by: Kirsty Mackay, Lucia Gambuzza
Nimesh Patel, MD, urges the FDA to reconsider SYD-101 as pediatric myopia drives earlier retinal damage in US children.
Advertisement
Advertisement
In pediatric retina clinics across Boston, we are seeing something that should concern every parent: teenagers already developing retinal damage linked to severe nearsightedness and excessive eye growth.
Related to this article
Prevent Blindness marks IED Week, October 19 to 25, as new therapies and pivotal trials reshape care for uveitis and thyroid eye disease.
Noab Banoub, a third year medical student, describes his journey into medicine and his view of ophthalmology's future.
Uveitis is uncommon, but it causes a disproportionate share of visual morbidity.
CLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.
Spectacle lenses with highly aspherical lenslets are safe and effective for reducing myopia progression in US children.
CHMP backs Accord Healthcare’s Lucentis biosimilar Fovlussea for nAMD, DMO, RVO and CNV ahead of an EC decision.
Enrollment in the licaminlimab trial closed above target, with two-thirds of 176 patients carrying a TNFR1 variant associated with stronger treatment response. Topline data are expected around year-end 2026.
Advertisement
Advertisement